8-K: Current report
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Danaher Corporation(0.0%),Danaher Ventures LLC(0.0%)
10-Q: Quarterly report
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Michael P. Rubin(45.9%),Northpond Ventures, LP(44.7%), etc.
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novalis LifeSciences Investments II, L.P.(19.99%),Novalis LifeSciences Investments II GP, LLC(19.99%), etc.
8-K: Current report
25: Notification of the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
4: Statement of changes in beneficial ownership of securities-Director Krueger Todd
4: Statement of changes in beneficial ownership of securities-Director Hodges Michael R.
4: Statement of changes in beneficial ownership of securities-Director Hlavinka Sarah E.
4: Statement of changes in beneficial ownership of securities-Director Golub Steven J
4: Statement of changes in beneficial ownership of securities-Director Weissman James B
3: Initial statement of beneficial ownership of securities-Director Krueger Todd
3: Initial statement of beneficial ownership of securities-Director Golub Steven J
No Data
No Data